Trial intelligence / Profile preview

Clozapine plus aripiprazole versus clozapine plus haloperidol in schizophrenia with incomplete response to clozapine

2006-004708-38Phase 4Completed

Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Start
Jun 2007
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in schizophrenia comparing Clozapine + aripiprazole with Clozapine + haloperidol (2 arms). Primary endpoint: Withdrawal from allocated treatment within 3 months of follow-up. Started Jun 2007; status: completed.

02

Drugs

clozapinearipiprazolehaloperidol
03

Conditions

schizophrenia

Beyond the preview

Go deeper on 2006-004708-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004708-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call